Sfoglia per AUTORE
DE SèZE J
Collezione AOU San Luigi di Orbassano

  

Items : 5

Myelin-oligodendrocyte glycoprotein antibody-associated disease. in The Lancet. Neurology / Lancet Neurol. 2021 Sep;20(9):762-772. doi: 10.1016/S1474-4422(21)00218-0.
2021
AOU San Luigi di Orbassano

Marignier R; Hacohen Y; Cobo-Calvo A; Pröbstel AK; Aktas O; Alexopoulos H; Amato MP; Asgari N; Banwell B; Bennett J; Brilot F; Capobianco M; Chitnis T; Ciccarelli O; Deiva K; De Sèze J; Fujihara K; Jacob A; Kim HJ; Kleiter I; Lassmann H; Leite MI; Linington C; Meinl E; Palace J; Paul F; Petzold A; Pittock S; Reindl M; et alii...

DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. in Annals of clinical and translational neurology / Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744. doi: 10.1002/acn3.51408. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Sormani MP; Salvetti M; Labauge P; Schiavetti I; Zephir H; Carmisciano L; Bensa C; De Rossi N; Pelletier J; Cordioli C; Vukusic S; Moiola L; Kerschen P; Radaelli M; Théaudin M; Immovilli P; Casez O; Capobianco M; Ciron J; Trojano M; Stankoff B; Créange A; Tedeschi G; Clavelou P; Comi G; Thouvenot E; Battaglia MA; Moreau T; Patti F; et alii...

Treatment of MOG antibody associated disorders: results of an international survey. in Journal of neurology / J Neurol. 2020 Dec;267(12):3565-3577. doi: 10.1007/s00415-020-10026-y. Epub 2020 Jul 4.
2020
AOU San Luigi di Orbassano

Whittam DH; Karthikeayan V; Gibbons E; Kneen R; Chandratre S; Ciccarelli O; Hacohen Y; de Seze J; Deiva K; Hintzen RQ; Wildemann B; Jarius S; Kleiter I; Rostasy K; Huppke P; Hemmer B; Paul F; Aktas O; Pröbstel AK; Arrambide G; Tintore M; Amato MP; Nosadini M; Mancardi MM; Capobianco M; Illes Z; Siva A; Altintas A; Akman-Demir G; et alii...

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS. in Multiple sclerosis (Houndmills, Basingstoke, England) / Mult Scler. 2019 Apr;25(4):591-600. doi: 10.1177/1352458518763080. Epub 2018 Mar 20.
2019
AOU San Luigi di Orbassano

Lavie C; Rollot F; Durand-Dubief F; Marignier R; Ionescu I; Casey R; Moreau T; Tourniaire P; Hutchinson M; D'Hooghe MB; Laplaud DA; Clavelou P; De Sèze J; Debouverie M; Brassat D; Pelletier J; Lebrun-Frenay C; Le Page E; Castelnovo G; Berger E; Hautecoeur P; Heinzlef O; Durelli L; Clerico M; Trojano M; Patti F; Vukusic S;

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. in Frontiers in neurology / Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019.
2019
AOU San Luigi di Orbassano

Barclay K; Carruthers R; Traboulsee A; Bass AD; LaGanke C; Bertolotto A; Boster A; Celius EG; de Seze J; Cruz DD; Habek M; Lee JM; Limmroth V; Meuth SG; Oreja-Guevara C; Pagnotta P; Vos C; Ziemssen T; Baker DP; Wijmeersch BV;